Unlocking the Power of Your Imaging Data: A New Era for Healthcare Providers

Healthcare institutions are custodians of countless diagnostic imaging studies — precious insights often locked within digital archives. What if this ever-growing reservoir of data could not only serve internal clinical needs but also fuel pioneering research and innovation? That’s where partnering with a modern data licensing platform transforms possibility into reality.

The Opportunity in Your Imaging Vault

Years of accumulated imaging — from X-rays and CT scans to MRIs — represent a gold mine for researchers and life sciences innovators. However, accessing and structuring this data for external use has traditionally been a daunting, time-consuming endeavor. This is where a specialized partner steps in: by entering a revenue-sharing agreement, healthcare providers can license their de-identified and structured data to researchers worldwide. Through such collaboration, your patient population isn’t just represented — it becomes integral to real-world discoveries and breakthroughs.

From Raw Data to Research-Ready Assets

The transformation begins with a commitment to data stewardship and privacy. By leveraging advanced de-identification tools — software crafted to strip protected health information from DICOM images and radiology reports — providers can ensure full compliance with HIPAA’s Safe Harbor standards.

Once sanitized, your data is standardized, structured, and delivered in formats that researchers can tap into quickly — whether through proprietary dashboards or APIs. This seamless integration means that what used to take months can now happen within days, accelerating study feasibility and enabling faster, smarter research cycles.

Prioritizing Patient Privacy and Trust

Trust and security form the foundation of any data partnership. That’s why every provider should work with a partner that holds the highest certifications in data protection — SOC 2 Type II, ISO 27001:2013, and full HIPAA compliance — demonstrating a deep commitment to patient confidentiality and institutional integrity.

Moreover, providers earn peace of mind knowing that their data, though powerful in its potential, remains fully de-identified — removing any risk of exposing identifiable patient information as it supports cutting-edge research.

Empowering Innovation — Together

Joining a global network of healthcare partners amplifies the impact of your contributions. Your institution plays a critical role in facilitating research across medical AI, diagnostic tools, device development, and beyond. In doing so, you help drive the creation of robust, diverse medical datasets that underpin breakthroughs — while also benefiting from a transparent, revenue-sharing model.

Not only does this enrich projects with real-world imaging data, but it also fosters smarter, evidence-based advancement across the healthcare ecosystem.

Efficient, Expert-Backed Implementation

Healthcare providers don’t need to build in-house workflows for de-identification, standardization, or delivery. A best-in-class data partner offers end-to-end management — from creating structured datasets to delivering them in machine-ready formats like DICOM, radiology reports, and associated metadata. Many offer curated, regulatory-grade datasets in response to specific cohort needs — the kind often required for clinical validation or AI model training.

Typically, these workflows are assisted by dedicated teams, ensuring accurate, timely, and relevant outcomes with minimal burden on institutional resources.

A Vision of Mutual Benefit and Innovation

By participating in such collaborations, healthcare providers help fuel innovation while ensuring they remain represented in solutions born from their patient populations. This model creates a virtuous cycle — your data not only generates value for your institution through revenue share but also contributes to advancements that may eventually circle back and benefit your patients directly.

In Summary

  • Unlock latent value: Turn years of archived imaging into powerful, research-ready datasets.
  • Ensure privacy: Partner with platforms that offer robust de-identification and full compliance with SOC 2, ISO 27001, and HIPAA.
  • Accelerate impact: Deliver structured, standardized data to researchers faster, making innovation a collaborative velocity rather than a sprint.
  • Share in success: Benefit through revenue-sharing while contributing to solutions that ultimately enhance patient care.

By embracing this approach, healthcare providers not only safeguard patient data — they actively empower science, innovation, and excellence in healthcare.

‍Connect with Segmed to find out how our high-quality, diverse, tokenized imaging datasets can support a myriad of research and development for medical devices R&D.

Location: United States

Comments

Post a Comment

Popular posts from this blog

The Future of AI in Medical Devices: FDA Guidelines and Value of Imaging Data

Image
Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing the medical device industry. These technologies are developing new methods to aid in the process of diagnosis, clinical decision-making, and the formation of treatment plans. AI and ML can identify anomalies and patterns to forecast patient outcomes from intricate data trends. They are making medical treatments more accurate and faster. As such algorithms evolve, they are being applied more and more in medical devices, enabling the devices to learn, adapt, and improve while being used. Medical device companies are applying these technologies to create innovative products that will better aid healthcare professionals and enhance patient care. One of the most significant advantages of AI/ML is the fact that it can learn from practical usage and experience, and improve its performance. Evolving FDA guidance on AI in medical devices The FDA also encourages AI and machine learning-based software as a medical device (...
Read more

Segmed’s Role in WHO Framework for AI Medical Devices

Image
Developing an AI algorithm that will make it into the clinical setting is not easy. The whole process is challenging, from gathering and curating medical data, to training, validating, and testing an AI model, and finally to deploying the algorithm in the clinics. The World Health Organization (WHO) recently published a  framework  that helps developers of AI-based software as a medical device (AI-SaMD) to understand the requirements of evidence generation from development to post-market surveillance [1]. It is expected that AI will significantly improve healthcare delivery and outcomes. The clinical application of AI models is, however, still challenging, not only in low- and middle-income countries, but also in high-income countries. One of the biggest hurdles for clinical application of AI algorithms is access to well-curated and diverse data used for training, validation, and testing. Many AI models are developed in an academic setting, based on homogeneous data from a sin...
Read more

Introducing Segmed’s LLM-based Data De-identification Playground

Here at Segmed, we’re simplifying access to real-world imaging data for AI research and collaboration. Due to this, we regularly process massive quantities of data - both radiology reports and associated DICOMs. To date, we have accumulated 60M+ patient records sourced from 1500+ sites across 5 continents (and this number continues to grow!). Medical data has incredible potential - researchers and developers in medical AI benefit from high-quality, standardized data to train, test and validate their algorithms. However, prior to sharing and collaborating on this data, patient privacy and confidentiality must be maintained. For this, said data must be effectively de-identified. What is data de-identification? Organizations that use patient data for research must prevent the exposure of protected health information (PHI). HIPAA (Health Insurance Portability and Accountability Act) mandates the removal of any information that could potentially lead to the re-identification of a patient....
Read more